Anti-obesity medication
An overview of medications used to treat obesity
Overview[edit | edit source]
Anti-obesity medications are pharmacological agents that reduce or control body weight. These medications alter one of the fundamental processes of the human body, weight regulation, by either altering appetite, absorption of calories, or increasing energy expenditure.
Mechanism of Action[edit | edit source]
Anti-obesity medications work through various mechanisms:
- Appetite Suppression: Some medications act on the central nervous system to suppress appetite. These include drugs that affect neurotransmitters such as serotonin, norepinephrine, and dopamine.
- Inhibition of Fat Absorption: Certain medications, such as orlistat, work by inhibiting the absorption of dietary fats in the intestine.
- Increased Energy Expenditure: Some drugs aim to increase the body's metabolic rate, thereby increasing energy expenditure.
Common Medications[edit | edit source]
Several medications are commonly used in the treatment of obesity:
- Orlistat: A lipase inhibitor that reduces the absorption of dietary fat.
- Phentermine: An appetite suppressant that affects the central nervous system.
- Lorcaserin: A serotonin receptor agonist that promotes satiety.
- Liraglutide: A glucagon-like peptide-1 (GLP-1) receptor agonist that increases insulin secretion and decreases appetite.
Side Effects[edit | edit source]
The use of anti-obesity medications can be associated with various side effects, which may include:
- Gastrointestinal Issues: Such as oily stools and flatulence, particularly with fat absorption inhibitors like orlistat.
- Cardiovascular Effects: Increased heart rate and blood pressure, especially with appetite suppressants.
- Central Nervous System Effects: Insomnia, nervousness, and dizziness.
Considerations and Contraindications[edit | edit source]
The prescription of anti-obesity medications requires careful consideration of the patient's overall health, potential side effects, and contraindications. These medications are typically recommended for individuals with a body mass index (BMI) of 30 or greater, or 27 or greater with comorbid conditions such as type 2 diabetes or hypertension.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD